EUVIMEDEUVIMED entdecken
Open Access

Clinical Specialty Expansion of AI-Enabled and Machine Learning–Enabled Medical Devices Authorized by the US Food and Drug Administration From 1995 to 2025: Longitudinal Content Analysis

Youn-Soo Lee, Bo-Young Youn

Journal of Medical Internet Research · 25.08.2026 · 28 · e103040-e103040

DOI: 10.2196/103040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Internet Research, online erschienen am 25.08.2026. Verfasst von Youn-Soo Lee und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Digital Healthcare, College of Health and Medical Science, Daejeon University, #505 Moonmugwan 62, Daehak-ro, Dong-gu, Daejeon, Republi…. Hauptthemen laut MEDLINE: United States Food and Drug Administration, Machine Learning, Equipment and Supplies, Artificial Intelligence. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The US Food and Drug Administration (FDA) has authorized AI-enabled and machine learning (ML)–enabled medical devices since 1995 and maintains a public registry of these authorizations. Prior analyses report that radiology dominates this landscape, but whether that concentration has persisted, intensified, or begun to reverse across 3 decades, particularly since 2022, remains insufficiently characterized.

Objective

This study aimed to (1) characterize the longitudinal growth of FDA-authorized AI/ML-enabled devices from 1995 to 2025, (2) quantify the temporal evolution of clinical specialty distribution across 4 eras, (3) identify emerging specialties, and (4) examine the association between manufacturer type and nonradiology authorization.

Methods

All 1430 devices in the FDA AI-Enabled Medical Devices registry (downloaded on March 1, 2026) with final marketing-authorization decisions through December 31, 2025, were analyzed. Devices were stratified by clinical specialty (FDA advisory committee panel) and 4 eras: Era 1 (1995‐2015), Era 2 (2016‐2019), Era 3 (2020‐2022), and Era 4 (2023‐2025). Concentration was quantified using the Herfindahl-Hirschman Index (HHI) with bootstrap CIs; the Cochran-Armitage test assessed trends in specialty share, with Bonferroni correction. Multivariable logistic regression estimated the odds of nonradiology authorization by manufacturer type and era, with an era-by-manufacturer interaction term. Sensitivity analyses used cluster-robust standard errors, a continuous authorization year variable, and Firth penalized regression. Manufacturers were classified using FDA records, Crunchbase, PitchBook, and company websites.

Results

Annual authorizations rose from a mean of 2.0 (SD 2.0) in Era 1 to a mean of 264 (SD 58.2) in Era 4, with 331 authorizations in 2025 alone; the 510(k) pathway accounted for 96.2% (1376/1430). Radiology led in every era but followed a nonmonotonic trajectory, rising from 35.7% (15/42, Era 1) to a peak of 85.5% (347/406, Era 3) before declining to 77.5% (614/792, Era 4), the first significant decline on record ( P =.001). The HHI fell from 0.738 (Era 3) to 0.612 (Era 4; bootstrap P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

United States Food and Drug AdministrationMachine LearningEquipment and SuppliesArtificial IntelligenceDevice ApprovalMedicineUnited StatesHumansLongitudinal Studies

Stichwörter der Autor:innen

AIFDA authorizationSoftware as a Medical DeviceUS Food and Drug Administrationclinical specialtydigital healthhealth informaticsinnovationmachine learningmedical devices

Autor:innen und Institutionen

  • Department of Digital Healthcare, College of Health and Medical Science, Daejeon University, #505 Moonmugwan 62, Daehak-ro, Dong-gu, Daejeon, Republic of Korea, +82-42-280-2062.
  • Department of Healthcare Management, College of Health and Medical Science, Daejeon University, #505 Moonmugwan 62, Daehak-ro, Dong-gu, Daejeon, 34520, Republic of Korea, +82-42-280-2062.

Zitieren

APA

Lee, Y. S., & Youn, B. Y. (2026). Clinical Specialty Expansion of AI-Enabled and Machine Learning–Enabled Medical Devices Authorized by the US Food and Drug Administration From 1995 to 2025: Longitudinal Content Analysis. Journal of Medical Internet Research, 28, e103040-e103040. https://doi.org/10.2196/103040

Vancouver

Lee YS, Youn BY. Clinical Specialty Expansion of AI-Enabled and Machine Learning–Enabled Medical Devices Authorized by the US Food and Drug Administration From 1995 to 2025: Longitudinal Content Analysis. Journal of Medical Internet Research. 2026;28:e103040-e103040. doi:10.2196/103040

BibTeX
@article{Lee2026,
  author = {Lee, Youn-Soo and Youn, Bo-Young},
  title = {Clinical Specialty Expansion of AI-Enabled and Machine Learning–Enabled Medical Devices Authorized by the US Food and Drug Administration From 1995 to 2025: Longitudinal Content Analysis},
  journal = {Journal of Medical Internet Research},
  year = {2026},
  volume = {28},
  pages = {e103040--e103040},
  doi = {10.2196/103040}
}
Kostenlos starten →